Impending Mental Health Issues During Coronavirus Disease 2019 - Time for Personalized Nutrition Based on the Gut Microbiota to Tide Over the Crisis?
- PMID: 35110993
- PMCID: PMC8801909
- DOI: 10.3389/fnins.2021.831193
Impending Mental Health Issues During Coronavirus Disease 2019 - Time for Personalized Nutrition Based on the Gut Microbiota to Tide Over the Crisis?
Abstract
Coronavirus disease 2019 (COVID-19) is a major pandemic facing the world today caused by SARS-CoV-2 which has implications on our mental health as well. The uncertain future, fear of job loss, lockdown and negative news all around have taken a heavy toll on the mental health of individuals from across the world. Stress and anxiety can affect the COVID-19 patients even more. Recent study suggests COVID-19 infection may lead to post-traumatic stress disorder (PTSD). Certain prebiotics and probiotics have been shown to have anxiolytic effect through gut microbiota modulation. Incidentally, preliminary report also suggests a differential microbial profile in COVID-19 patients as compared to healthy individuals. Gut microbiota's role in anxiety and depression is well studied. The importance of the "gut-brain" axis has been implicated in overall mental health. It is known that diet, environmental factors and genetics play an important role in shaping gut microbiota. Trials may be initiated to study if personalized diet and supplementation based on individual's gut microbiome profile may improve the general mental well-being of people prone to anxiety during this pandemic. Also, COVID-19 patients may be provided personalized nutritional therapy based on their gut microbiota profile to see if PTSD and anxiety symptoms can be alleviated.
Keywords: COVID-19; gut microbiome; mental health; nutrition; precision medicine.
Copyright © 2022 Dhar.
Conflict of interest statement
DD is the Director of Leucine Rich Bio (LRB), which is South Asia’s first microbiome company.
Figures
Similar articles
-
Gut microbiota and Covid-19- possible link and implications.Virus Res. 2020 Aug;285:198018. doi: 10.1016/j.virusres.2020.198018. Epub 2020 May 13. Virus Res. 2020. PMID: 32430279 Free PMC article. Review.
-
Alteration of the gut microbiota's composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters.Gut Microbes. 2022 Jan-Dec;14(1):2100200. doi: 10.1080/19490976.2022.2100200. Gut Microbes. 2022. PMID: 35830432 Free PMC article.
-
Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.mBio. 2022 Apr 26;13(2):e0380121. doi: 10.1128/mbio.03801-21. Epub 2022 Mar 7. mBio. 2022. PMID: 35254129 Free PMC article.
-
The gut-microbiota-brain axis in a Spanish population in the aftermath of the COVID-19 pandemic: microbiota composition linked to anxiety, trauma, and depression profiles.Gut Microbes. 2023 Jan-Dec;15(1):2162306. doi: 10.1080/19490976.2022.2162306. Gut Microbes. 2023. PMID: 36651663 Free PMC article.
-
Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic.Trends Food Sci Technol. 2021 Feb;108:187-196. doi: 10.1016/j.tifs.2020.12.009. Epub 2020 Dec 14. Trends Food Sci Technol. 2021. PMID: 33519087 Free PMC article. Review.
Cited by
-
The Gut-Brain Axis and the Microbiome in Anxiety Disorders, Post-Traumatic Stress Disorder and Obsessive-Compulsive Disorder.Curr Neuropharmacol. 2024;22(5):866-883. doi: 10.2174/1570159X21666230222092029. Curr Neuropharmacol. 2024. PMID: 36815632 Free PMC article. Review.
-
Microbiota based personalized nutrition improves hyperglycaemia and hypertension parameters and reduces inflammation: a prospective, open label, controlled, randomized, comparative, proof of concept study.PeerJ. 2024 Jun 26;12:e17583. doi: 10.7717/peerj.17583. eCollection 2024. PeerJ. 2024. PMID: 38948211 Free PMC article. Clinical Trial.
-
Probiotics in the Management of Mental and Gastrointestinal Post-COVID Symptomes.J Clin Med. 2022 Aug 31;11(17):5155. doi: 10.3390/jcm11175155. J Clin Med. 2022. PMID: 36079082 Free PMC article. Review.
References
-
- Allen A. P., Hutch W., Borre Y. E., Kennedy P. J., Temko A., Boylan G., et al. (2016). Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl. Psychiatry 6 e939–e939. 10.1038/tp.2016.191 - DOI - PMC - PubMed
-
- Balikci A., Uzun O., Erdem M., Doruk A., Cansever A., Ates M. A. (2014). Ayaktan izlenen hastalarda antidepresan tedaviye uyunçu bozan ilaç yan etkileri. Klinik Psikofarmakoloji Bulteni 24, 69–75. 10.5455/bcp.20120827114140 - DOI
LinkOut - more resources
Full Text Sources
Miscellaneous